Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 4 Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 2 Stomach Neoplasms 1 Progression-free Survival;Progression-free Survival;Disease Control Rate; Safety 1 Lung Neoplasms 1 Liver Neoplasms 1 Glioma 1 Glioblastoma 1 Breast Cancer Organoids 1 Advanced Gastric Cancer 1

Interventions

Hepatectomy 10 Blood Specimen Collection 9 Sorafenib 7 Polymerase Chain Reaction 4 Biopsy 4 regorafenib 3 Mass Spectrometry 3 Liver Transplantation 3 Immunohistochemistry 3 Chemoembolization, Therapeutic 3 Walking Speed 2 Surveys and Questionnaires 2 Psychiatric Rehabilitation 2 Magnetic Resonance Imaging 2 Gene Expression Profiling 2 Bevacizumab 2 trastuzumab deruxtecan 1 taxane 1 spartalizumab 1 sintilimab 1 lenvatinib 1 gadolinium ethoxybenzyl DTPA 1 donafenib 1 carmofur 1 camrelizumab 1 cabozantinib 1 atezolizumab 1 apatinib 1 anlotinib 1 Yttrium-90 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Liver Neoplasms × apatinib × Clear all

NCT05713994 2025-03-25

CCGLC-001

Tongji Hospital

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡